Charles E. Sheedy, 10% Owner at Nuo Therapeutics, Inc. (AURX), bought 62,500 shares at $2.00 ($125K) on 2023-08-01, disclosed to the SEC on 2023-08-04.
Open-market purchase of $125k AURX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| AURX | BUY | 2024-05-21 | $75K | — | Filing → |
| AURX | BUY | 2023-12-20 | $75K | — | Filing → |
| AURX | BUY | 2022-05-02 | $805K | — | Filing → |